Chronic fluoxetine treatment alters the structure, connectivity and plasticity of cortical interneurons

Ramon Guirado1, Marta Perez-Rando1, David Sanchez-Matarredona1

  • 1Neurobiology Unit and Program in Basic and Applied Neurosciences, Cell Biology Department,Universitat de València,Spain.

Insights

Selective serotonin reuptake inhibitors like fluoxetine may reopen critical periods by altering inhibitory neuron structure. This study shows fluoxetine induces plasticity in adult mouse interneurons, impacting brain development mechanisms.

Area of Science:

  • Neuroscience
  • Molecular Psychiatry
  • Developmental Neuroscience

Background:

  • Antidepressants, including fluoxetine, are hypothesized to induce neuronal structural plasticity, mimicking juvenile brain states.
  • The mechanisms behind this 'reopening' of critical periods remain unclear, but inhibitory networks are implicated.
  • Recent research highlights the role of inhibitory networks in fluoxetine-induced structural plasticity.

Purpose of the Study:

  • To investigate the effects of chronic fluoxetine treatment on neuronal structure in the hippocampus and medial prefrontal cortex (mPFC).
  • To examine changes in plasticity-related molecules and interneuron morphology following fluoxetine administration.
  • To elucidate the role of interneurons in fluoxetine-induced structural plasticity and critical period reopening.

Main Methods:

  • Utilized transgenic mice with eGFP-labeled interneurons for detailed analysis.
  • Administered chronic fluoxetine treatment to adult mice.
  • Analyzed molecular markers (PSA-NCAM, GAD67/65, synaptophysin, parvalbumin) and synaptic structures in the hippocampus and mPFC.
  • Quantified dendritic spine density on interneurons in the mPFC.

Main Results:

  • Fluoxetine treatment increased expression of plasticity molecules (PSA-NCAM, GAD67/65, synaptophysin).
  • Observed a decrease in parvalbumin-expressing interneurons ensheathed by perineuronal nets.
  • Noted a trend towards reduced perisomatic inhibitory puncta on pyramidal neurons and increased puncta on interneurons in the mPFC.
  • Found increased dendritic spine density on mPFC interneurons after chronic fluoxetine exposure.

Conclusions:

  • Chronic fluoxetine treatment induces structural changes in adult cerebral cortex inhibitory neurons.
  • These changes may involve alterations in plasticity-related molecules or the extracellular matrix surrounding interneurons.
  • The findings suggest a potential mechanism for how fluoxetine influences plasticity, possibly by affecting interneurons crucial for juvenile critical periods.

Related Concept Videos

Long-term Depression01:05

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
27.3K
Long-term Depression01:03

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
2.6K
Neuroplasticity01:01

Neuroplasticity

Neuroplasticity reflects the brain's remarkable capacity to adapt and evolve, responding dynamically to learning, experiences, or injury by reorganizing its neural circuitry. This reorganization involves creating new neural connections and refining old ones through a series of biological processes that contribute to the brain's lifelong development and adaptability.
2.6K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
2.3K
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.4K
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
928